Efficacy of System Constellations in a General Population
8. februar 2012 oppdatert av: Jochen Schweitzer-Rothers, Heidelberg University
Randomized Controlled Trial on the Efficacy of System Constellations on Psychological Well-being in a General Population Based Sample
The purpose of this study is to investigate the efficacy of system constellations in a monocentric, single-masked randomized controlled trial.
The method of system constellations refers to an approach which integrates ideas from family systems therapy with elements from psychodrama. The constellations are conducted in a group based seminar-setting, each seminar lasting three days.
Based on the model of a general psychotherapy and the consistency theory, the effects of system constellations on psychological functioning are explored.
It is predicted that participation in a system constellation seminar changes the level of psychological functioning at 4 months.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
216
Fase
- Fase 2
- Fase 3
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Baden-Württemberg
-
Heidelberg, Baden-Württemberg, Tyskland, 69115
- Institute of Medical Psychology, University Hospital Heidelberg
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- agreement to participate in a 3-day system constellations seminar
- agreement to be randomized into treatment group or control group (waiting condition)
- agreement not to participate in another system constellation seminar until completion of study
Exclusion Criteria:
- acute suicidal tendency
- acute psychotic episode
- acute drug or alcohol intoxication
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: system constellations seminar (exp. group)
Study participants randomized to this group receive the intervention (system constellation seminar) 4 months prior to the control group
|
individual-centered intervention in a group setting, duration 3 days
|
|
Eksperimentell: system constellations seminar (control group)
Study participants randomized to this group receive the intervention (system constellations seminar) 4 months after the experimental group.
|
individual-centered intervention in a group setting, duration 3 days
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline in psychological well-being at 2 weeks and four months
Tidsramme: Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment
|
Psychological well-being will be assessed using the 'Outcome Questionnaire' in its German version (EB-45).
The EB-45 is a brief 45-item self report outcome/tracking instrument designed for repeated measurement of client progress through the course of psychotherapy and following termination.
The scales of the EB-45 measure symptom distress, interpersonal functioning, and social role.
|
Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline in Psychological distress after 2 weeks and 4 months
Tidsramme: Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment
|
The FEP-2, 40-item self report questionnaire, measures psychological distress according to the phase model of therapeutic change as well as the interpersonal model of psychological distress.
|
Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment
|
|
Change from Baseline in Incongruence at 2 weeks and 4 months
Tidsramme: Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment
|
Motivational incongruence is defined as the unsatisfactory realization of motivational goals and is based on the concept of General Psychotherapy by Klaus Grawe.
The Incongruence Questionnaire (INK) is an instrument that assesses motivational incongruence, defined as the discrepancy between a person's motivational goals and his/her perception of reality.
The short version of this questionnaire that will be used in our study (K-INK) comprises 23 items.
|
Baseline, day of treatment, 2 weeks after treatment, 4 months after treatment
|
|
Goal achievement at 2 weeks and 4 months
Tidsramme: day of treatment, 2 weeks after treatment, 4 months after treatment
|
Goal achievement will be assessed using Goal Attainment Scaling as a method for the assimilation of achievement in a number of individually set goals into a single aggregated 'goal attainment score', providing a person-centred outcome, focused on that individual's priorities.
Goal attainment scaling is operationalized by an open-ended question, in which study participants descriobe their individual goals.
In a second step these goals will be coded according to the Bern inventory of psychotherapy goals (BIT-C).
|
day of treatment, 2 weeks after treatment, 4 months after treatment
|
|
Change from Baseline in 'Experiences in family and organisational systems' at 2 weeks and 4 months
Tidsramme: day of treatment, 2 weeks after treatment, 4 months after treatment
|
The subjective quality of family and organizational systems will be assessed by the HFES (Heidelberger Fragebogen zum Erleben in Systemen: Heidelberg Questionnaire on experiences in systems), a self-constructed questionnaire comprising 24 items.
|
day of treatment, 2 weeks after treatment, 4 months after treatment
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Studieleder: Jochen Schweitzer-Rothers, Professor, Institute of Medical Psychology, University Hospital Heidelberg/Germany
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. februar 2011
Primær fullføring (Faktiske)
1. desember 2011
Studiet fullført (Faktiske)
1. desember 2011
Datoer for studieregistrering
Først innsendt
4. mai 2011
Først innsendt som oppfylte QC-kriteriene
10. mai 2011
Først lagt ut (Anslag)
11. mai 2011
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
9. februar 2012
Siste oppdatering sendt inn som oppfylte QC-kriteriene
8. februar 2012
Sist bekreftet
1. februar 2012
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- SFBC11
- SFB 619 project C11 (Annen identifikator: German Research Council)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .